CUE
Cue Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.44
−0.83%Margins
Gross margin
99.7%
EBITDA margin
-254.7%
EBIT margin
-262.0%
Net margin
-435.8%
FCF margin
-133.2%
-7104.2%
Return on equity
-534.4%
Return on assets
-887.3%
Return on invested capital
1.22x
Asset turnover
-$50.0M
Cash from operations
$2.39
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026